secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001731122-26-000221
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Lunai Bioworks receives Nasdaq delisting notice; appeals hearing requested
--------------------------------------------------------------------------

- Notice received Feb 6, 2026: bid price closed below $1.00 for 30 consecutive business days through Feb 5, 2026.
- Ineligible for 180-day compliance period due to 1-for-10 reverse stock split on Sep 30, 2025 (Nasdaq Rule 5810(c)(3)(A)(iv)).
- Suspension and Form 25 filing scheduled for Feb 18, 2026 unless hearing request stays action.
- Company timely requested hearing before Nasdaq Hearings Panel by Feb 13, 2026; outcome uncertain.
- Delisting would deregister securities under Section 12(b) of Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000221/0001731122-26-000221-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000221/e7323_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000221

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer